Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Anthocyanins, a group of flavonoid compounds responsible for the red, purple, and blue colors in many fruits and vegetables, have been studied for their potential to reduce some side effects of chemotherapy. The justification for their use is based on scientific investigation, though the body of evidence remains limited and largely preclinical or observational in nature. Anthocyanins possess antioxidant, anti-inflammatory, and cytoprotective properties, which theoretically could help mitigate oxidative stress and inflammation induced by chemotherapy agents. Several animal and cell culture studies have shown that anthocyanins can reduce markers of oxidative damage, inflammation, and even some toxic effects on tissues such as the gastrointestinal tract and the heart, which are common targets of chemotherapy side effects.

Some small clinical studies and pilot trials have explored the supportive use of anthocyanin-rich foods or extracts (such as bilberry or blackcurrant) in cancer patients undergoing chemotherapy. These have reported improvements in parameters like oxidative stress, immune function, and subjective well-being, but robust clinical trials are lacking. There is no established protocol or dosage, and anthocyanin supplementation is not a standard part of supportive care in oncology. Thus, while there is a scientific rationale and some preliminary evidence, it is not strong or conclusive; anthocyanins are not yet widely recommended as a validated therapy to reduce chemotherapy side effects. More rigorous research is needed to determine efficacy, safety, and appropriate use.

More about anthocyanins
More about Chemotherapy (reducing side effects)

Other ingredients used for Chemotherapy (reducing side effects)

Other health conditions supported by anthocyanins

Products containing anthocyanins